Synthetic peptide platform to make orally active, room-temperature vaccines
Researchers are developing a vaccine production platform designed to make ingestible, temperature-stable synthetic drugs.
Researchers are developing a vaccine production platform designed to make ingestible, temperature-stable synthetic drugs.
Sterling Pharma Solutions says it will boost its chromatography services with Nanologica’s silica particles production technology.
Thermo Fisher Scientific has announced plans to build a supply chain facility, which it says will increase capacity for cold and ambient clinical trial materials in Europe.
An online portal designed to connect sponsors with trial sites and contract research organizations has been launched by the Victorian state government in Australia.
Thermo Fisher Scientific says its proposal to move manufacturing and R&D operations from Ashford, Kent to existing sites in Mexico, China and Denmark was a “very difficult decision.”